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Abstract
Objectives The lecithin/sphingomyelin (L/S) ratio and the
lamellar body count (LBC) can be used to predict respira-
tory distress syndrome (RDS).
Design We performed a retrospective cohort study among
consecutive women who underwent amniotic Xuid sam-
pling for the assessment of fetal lung maturity. Logistic
regression was used to construct models for the prediction
of RDS in three gestational age categories, with models
based on clinical characteristics only, clinical characteristics
and the LBC, and on clinical characteristics and L/S ratio.
Results When amniotic Xuid was collected <30 weeks,
the speciWcity of the LBC was 30% and the sensitivity
100%. Addition of the L/S ratio increased the speciWty to
60%, for a sensitivity of 100%. When amniocentesis was
performed between 30 and 33 weeks, addition of the L/S
ratio only marginally improved the performance of the
LBC.
Conclusions At a gestational age <30 weeks, the L/S ratio
has additional value over the LBC. Above 30 weeks of ges-
tation, single use of the LBC seems suYcient.
Keywords Fetal lung maturity · Lamellar body count · 
L/S ratio · Respiratory distress sydrome (RDS)
Introduction
The lecithin/sphingomyelin (L/S) ratio and the lamellar
body count (LBC) are two invasive tests used to assess fetal
lung maturity in pregnancies at risk for preterm delivery
[1–3]. Many studies have reported on the accuracy of these
tests. In a recent meta-analysis in which we summarized six
studies in which both tests were compared, the LBC was
found to be at least as accurate as the L/S ratio [4]. How-
ever, accuracy is not the only issue that is of importance in
establishing their value for clinical practice. In this context,
Richardson and HeVner [5] recently stated that although
tests for fetal lung maturity were mature, their interpreta-
tion was not. They hypothesized that due to the high risk of
lung immaturity at low gestation, testing for fetal lung
maturity was not useful before a gestational age of
32–33 weeks. On the other hand, they assumed the preva-
lence of RDS and other complications after a gestational
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age of 37 weeks to be low, thus implicating that testing was
also not useful near term. They suggested that there is a
need for studies in which pre-test probabilities, test perfor-
mance and post-test probabilities are related. The aim of the
present study was therefore to evaluate the contribution of
L/S ratio and LBC in the prediction of fetal lung immatu-
rity. To do so, we constructed prediction models using
patient characteristics and then evaluated whether the pre-
diction changed after adding results from L/S ratio and
LBC.
Methods
Patients
The study was performed in two large teaching hospitals
with a tertiary referral function for perinatal medicine in
The Netherlands. We reviewed in retrospect the medical
Wles of consecutive women who underwent amniotic Xuid
sampling for the assessment of fetal lung maturity. Amni-
otic Xuid was collected by transabdominal amniocentesis.
Exclusion criteria were an uncertain gestational age, fetal
anomalies which could possibly interfere with the occur-
rence of RDS, and monoamniotic twin pregnancies.
Women with ruptured membranes in whom amniotic Xuid
was collected vaginally, were also excluded from the study.
When repeated sampling was performed in one woman,
only the last sample before delivery was used for analysis.
For each patient, we recorded the reason for admission, use
of antenatal glucocorticoids and tocolytic drugs, ultrasound
and Doppler Wndings, multiple pregnancy, gestational age
at time of testing and at delivery, contamination of the sam-
ples with blood or meconium and neonatal outcome. Gesta-
tional age was calculated from the Wrst day of the last
menstrual period, or from Wrst trimester ultrasonography.
All samples were obtained for clinical purposes. Clinical
management of pregnancies was based on the maternal and/
or fetal condition and on the outcome of the fetal lung
maturity tests. The occurrence of RDS was diagnosed
according to clinical symptoms of respiratory stress and
Wndings on chest radiographs [6]. Clinical symptoms of
respiratory stress included the need for continuous positive
airway pressure for at least 24 h. Moreover, an experienced
neonatologist, who was unaware of the outcome of the fetal
lung maturity tests, reviewed all chest radiographs of the
infants with reported RDS. Women of whom the outcome
of the infant was unknown or of whom the infant died
within 24 h after delivery without developing RDS, were
excluded from the analysis.
Multiple regression analysis indicated that both the L/S
ratio and the LBC varied statistically signiWcant with gesta-
tional age. Both were statistically diVerent in the patients
who delivered more than 14 days after amniocentesis (both
P values <0.01). However, the L/S ratio and the LBC
diVered not statistically signiWcant between women who
delivered within 48 h after amniocentesis, women that
delivered between 48 h and 7 days after amniocentesis, and
women who delivered between 7 and 14 days after amnio-
centesis [7].
In view of these data, we excluded women who deliv-
ered more than 14 days after the amniocentesis. The exclu-
sion of these women introduces a bias called veriWcation
bias, since women with low fetal lung maturity test results
were more likely to be excluded than women with normal
or high fetal lung maturity test results [8]. We controlled
for veriWcation bias by calculating for each women the
probability of veriWcation, i.e. the probability that a woman
delivered within 2 weeks after amniotic Xuid collection [9].
This probability was calculated with a logistic regression
model, in which the occurrence of veriWcation was the
dependent variable, and gestational age and the results of
fetal lung parameters were the independent variables [10].
This probability was used as a weight factor in the statisti-
cal calculations that are described later in the “Methods”
section.
Laboratory methods
Immediately after arrival at the laboratory, amniotic Xuid
samples were centrifuged for 5 min at 450g. In one center
the LBC was performed on a Technicon H*1 haematology
analyser (Bayer Diagnostics, Tarrytown, USA) during the
Wrst 3 years and on a Cell-Dyn 4000 (Abbott Diagnostics,
Santa Clara, USA) from 1999. The other center used only
the Cell Dyn 1600 (Abbott Diagnostics, Santa Clara USA).
Measurements on the Technicon H*1 were made with the
laser cell counter (helium neon laser at 632.8 nm) with
measurement on the basis of low angle scatter signal with
Wxed thresholds for counting between 2  and 30 m
(platelet channel). Measurements on the Cell-Dyn were
made with the aperture impedance cell counter in the eryth-
rocyte/platelet channel. The histogram of the platelets was
used for the LBC. Both methods were calibrated against
each other. In both centers the L/S ratio was determined by
thin-layer chromatography according to Gluck et al. [1] and
performed in duplicate. The variation between the measure-
ments was about 15% for both the L/S ratio and the LBC.
We tested several amniotic Xuid samples in both centers to
verify comparability of L/S and LBC results and did not
Wnd statistically signiWcant diVerences.
Statistics
We distinguished three categories of women based on the
gestational age at amniocentesis: (1) <30 weeks; (2)Arch Gynecol Obstet (2010) 281:15–21 17
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between 30 and 33 weeks; (3) >33 weeks. In each category,
we used stepwise logistic regression to construct a model
for the prediction of RDS, using clinical characteristics, but
not the results of L/S ratio and LBC. Clinical characteristics
considered were reason for admission, use of antenatal glu-
cocorticoids and tocolytic drugs, multiple pregnancy, ultra-
sound Wndings, diabetes type I, gestational diabetes, gender
of the fetus, and gestational age at time of amniocentesis.
The probability of veriWcation was used as relative weight
in this logistic model. Selection of variables is usually per-
formed with a signiWcance level of 0.05. However, the
incorrect exclusion of a prognostic factor would be more
deleterious than including too many factors [9]. Therefore,
multivariable analysis included all variables with a P value
<0.30. We then added the LBC to the model in the three
gestational age groups. Subsequently, we plotted the proba-
bility of RDS as predicted by the model without the LBC
against the probability of RDS predicted by the model with
the LBC added to the clinical characteristics. Similarly, the
L/S ratio was forced into the models with the LBC, and we
then plotted the probability predicted with the model with
the LBC added to the clinical characteristics against the
probability predicted with L/S ratio added to the clinical
characteristics.
Results
During the study period, 363 women met the inclusion cri-
teria. From these women, 13 infants died within 24 h with-
out developing RDS and from 16 infants we had an
incomplete follow up because of transport to another hospi-
tal. There were 154 women who delivered within 48 h after
amniocentesis, 82 who delivered within 48 h and 7 days, 49
who delivered within 7 and 14 days, and 49 who delivered
more than 14 days after amniocentesis. For the analysis, we
excluded the 49 women who delivered more than 14 days
after amniocentesis. Thus, 285 women were available for
analysis, of whom 61 infants (21%) developed RDS. In 31
women (11%) the L/S ratio and in 19 women (7%) the LBC
was not determined.
There were 26 mother with diabetes type I (7.9%) and 32
mothers with gestational diabetes (9.7%). Tocolysis was
applied in 44 women (14%), whereas 167 women (9.7%)
had had steroids antenatally. There were 152 male babies
(46%), 85 (26%) were born from a multiple pregnancy and
69 were below the 5th percentile (21%). The logistic mod-
els that were constructed to predict the occurrence of RDS
are shown in Table 1. Diabetes of the mother [OR 3.3, 95%
conWdence interval (CI) 0.58–18, P value 0.18], antenatal
administration of glucorticosteroids (OR 0.97, 95% CI
0.29–3.3, P value 0.96), use of tocolysis (OR 0.31, 95% CI
0.06–1.5, P value 0.14), being born from a multiple preg-
nancy (OR 0.37, 95% CI 0.11–1.2, P value 0.105),and
being male (OR 0.74, 95% CI 0.24–2.3, P value 0.60),
whereas fetal growth as well as the L/S ratio and the LBC
were veriWed (Table 1).
There were 50 women who underwent amniocentesis
before 30 weeks, and 41 of them delivered within 14 days
after amniocentesis, i.e. fetal lung maturity status could
be veriWed. From these women 25 infants developed RDS
(25/42 = 61%). Figure 1a shows the probability of RDS as
predicted without fetal lung maturity tests in relation to the
probability of RDS that was calculated after taking into
account the result of the LBC. This Figure shows that with-
out performing fetal lung maturity tests, it is not possible to
distinguish between infants who will develop RDS and
infant who will not develop RDS. After taking into account
the results of the LBC, two out of 16 women whose infant
did not develop RDS could have been identiWed as being at
low risk, i.e. below 10%. Figure 1b shows the result of add-
ing the L/S ratio to the model with the LBC. Another Wve
women whose infant did not develop RDS could be identi-
Wed as being at low risk, thus increasing the speciWcity to
over 60%, for a sensitivity of 100%.
There were 96 women with amniotic Xuid collection
between 30 and 33 weeks and 76 delivered within 14 days
after the procedure. From these women, 25 infants devel-
oped RDS (25/76 = 33%). Figure 2a shows the probability
of RDS as predicted without fetal lung maturity tests in
relation to the probability of RDS that was calculated after
taking into account the results of the LBC. Without per-
forming fetal lung maturity tests, it appeared not to be pos-
sible to distinguish between women whose infant will
develop RDS and whose infant will not develop RDS
(Fig. 2a). However, after taking into account the result of
the LBC, 20 out of 51 women whose infant did not develop
RDS could have been identiWed as being at low risk, at the
Table 1 The three logistic models that were used to calculate the
probability of RDS
The probability can be calculated by the formula P =e x p ( )/
(1 + exp()). The  can be calculated from the patient characteristics;
for example for a woman with a gestational age of 210 days and an esti-
mated fetal growth on the p25 in which  is calculated as 19.7321 –
210 £ 0.0951 + 25 £ 0.0245
Model without 
fetal lung 
maturity tests
Model 
with LBC
Model with 
L/S ratio
Beta 19.7321 22.2879 12.3899
Gestational 
age (per day)
–0.0951 –0.1024 –0.0502
Fetal growth (%) 0.0245 0.0369 0.0326
LBC (1,000/L) – –0.0752 –
L/S ratio – – –1.233218 Arch Gynecol Obstet (2010) 281:15–21
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cost of one false-negative test result. Figure 2b shows the
result of adding the L/S ratio to the model with the LBC.
Only another three women whose infant did not develop
RDS could be identiWed as being at low risk, whereas the
false-negative test result according to the LBC was identi-
Wed correctly as being at high risk due to a low L/S ratio.
There were 184 women who had an amniocentesis after
33 weeks and 167 of them delivered within 14 days after
the procedure. From these women 10 infants developed
RDS (10/167 = 6%). Figure 3a shows the probability of
RDS as predicted without fetal lung maturity tests in rela-
tion to the probability of RDS that was calculated after tak-
ing into account the results of the LBC. Without fetal lung
maturity tests, about 25 of the 157 women whose infant did
not develop RDS could be identiWed as being at low risk.
After taking into account the LBC, another 25 women
whose infant did not develop RDS could have been identi-
Wed as being at low risk, without false-negative test results.
Figure 3b shows the result of adding the L/S ratio to the
model with the LBC. There were only 38 women in whom
the L/S ratio was performed. Addition of the results of the
L/S ratio to the model resulted only in one out of 13 cases
in which the probability of RDS changed from more than
10% to a probability of lower than 10%.
Discussion
This study reports on the contribution of L/S ratio and LBC
to the prediction of fetal lung immaturity. To do so, we con-
structed prediction models using patient characteristics, and
then evaluated whether the prediction changed after adding
results from L/S ratio and LBC. In women who had an
amniocentesis below 30 weeks, the speciWcity of the LBC
was 30% for a 100% sensitivity. Use of the L/S ratio
increased the speciWcity to 60%, for a sensitivity of 100%.
In women who had amniocentesis between 30 and
33 weeks, the speciWcity of the LBC was 40% for a sensi-
Fig. 1 Prediction model for fe-
tal lung immaturity at gesta-
tional age <30 weeks. a 
Probability of RDS, without tak-
ing into account fetal lung matu-
rity tests, as compared to the 
probability calculated after tak-
ing into account the result of the 
LBC. b Probability of RDS, tak-
ing into account only LBC and 
after addition of the L/S ratio
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Fig. 2 Prediction model for 
fetal lung immaturity at gesta-
tional age 30–33 weeks. a 
Probability of RDS, without 
taking into account fetal lung 
maturity tests, as compared to 
the probability calculated after 
taking into account the result of 
the LBC. b Probability of RDS, 
taking into account only LBC 
and after addition of the 
L/S ratio
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tivity of 96%. Addition of the L/S ratio improved the speci-
Wcity only slightly. In women who had amniocentesis
above 33 weeks, 15% could have been identiWed as being at
low risk before amniocentesis. Addition of the LBC
increased the speciWcity to 30%.
Although we had a relatively large sample size, and we
used a P value as threshold for selection in the model of
0.10, other factors known to be associated with the devel-
opment of RDS, such as maternal diabetes, being born
from a multiple pregnancy and being a male fetus were
not selected in our model. Individual patient data meta-
analysis, in which data from individual studies are added,
might be a solution to overcome this problem of statistical
power.
When the results of fetal lung maturity tests are divided
in ‘mature’ and ‘immature’ results, which is done in most
studies on fetal lung maturity testing, the gradual matura-
tion of the fetal lung is not taken into account. We divided
our population in three categories based on gestational age
and calculated the pre-test probability for RDS based on the
gestational age. Unfortunately, the gestational age group
>33 weeks covered a wide period with diVerent risks for
RDS. However, the number of patients and the number of
infants with RDS were too low to divide this population
into subgroups. Another limitation of our study is that the
severity of RDS could not be taken into account.
The novel approach used in this study is the introduction
of prediction models, rather than the use of Wxed cut-oV
levels for LBC or L/S ratio. As a consequence, the interpre-
tation of the LBC or L/S ratio is diVerent at diVerent gesta-
tional ages. As can be seen from the constructed logistic
models as well as from the Figs. 1, 2 and 3, a lower gesta-
tional age results in a higher probability of RDS, and thus
requires a relatively high LBC or L/S ratio for a similar
post-test probability, as compared to a similar patient
undergoing the tests at a higher gestational age [5].
In studies on fetal lung maturity testing, analysis is often
limited to women who delivered within 72 h after amniotic
Xuid collection. Thereafter, it is thought that the test result
is not a reliable measure of the actual state of fetal lung
maturity anymore. However, as the decision to accept
delivery is likely to depend on the results of the tests, the
number of cases with a test result indicating mature fetal
lungs, will be over represented if women who delivered
after 72 h are excluded. The bias introduced by excluding
women who delivered after a certain interval after amnio-
centesis is called veriWcation bias. In our previous study,
only women who delivered more than 2 weeks after amni-
otic Xuid collection appeared to have a lower L/S ratio [7].
To correct for veriWcation bias, we calculated the probabil-
ity for veriWcation for the included women and used this
probability as relative weight in the logistic model to calcu-
late the risk for RDS [8, 9].
If we want to assess whether an amniocentesis to obtain
information on fetal lung maturity is useful, we should con-
sider both the prevalence of RDS as well as the additional
information obtained from either the LBC or the L/S ratio.
From the prediction models that were developed in this
study, we can obtain the predicted prevalence of
RDS-obtained without testing, the predicted prevalence of
RDS-obtained after testing with the LBC and the predicted
prevalence of RDS-obtained after testing with the L/S ratio.
If we assume an arbitrarily chosen threshold probability of
RDS, and decide to postpone delivery in case the probabil-
ity of RDS is over the threshold, then we can discriminate
four categories of patients: (1) patients in whom delivery is
delayed in the absence of fetal lung maturity (true-posi-
tives, ‘wait correctly’); (2) patients in whom delivery is
delayed in the presence of fetal lung maturity (false-posi-
tives, ‘wait incorrectly’); (3) patients in whom delivery is
allowed in the absence of fetal lung maturity (false-nega-
tives, ‘deliver incorrectly’); and (4) patients in whom deliv-
Fig. 3 Prediction model for 
fetal lung immaturity at gesta-
tional age >33 weeks. a Proba-
bility of RDS, without taking 
into account fetal lung maturity 
tests, as compared to the 
probability calculated after 
taking into account the result of 
the LBC. b Probability of RDS, 
taking into account only LBC 
and after addition of the 
L/S ratio
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ery is allowed in the presence of fetal lung maturity (true-
negatives, ‘deliver correctly’).
Table 2 shows the distribution of these four categories
for a gestational age <30 weeks, when the threshold proba-
bility at which delivery is delayed, is set at 45%. The table
shows a Wctive cohort of 100 patients, with a prevalence of
RDS of 61%. Clinical management based on the LBC
would imply that 5 of these 61 women would be allowed to
deliver despite fetal lung immaturity, as compared to 7
without invasive testing. On the other hand, delivery in
presence of fetal lung maturity, thus preventing the risk of
antepartum asphyxia or even intrauterine death, would be
allowed in 17 women, instead of 15 without invasive test-
ing. Table 2 also shows that addition of the L/S ratio would
decrease the number of ‘incorrect’ deliveries to 3, whereas
the number of correctly delivered women would increase to
21.
Table 3 shows the situation for a gestational age between
30 and 33 weeks. For the construction of this table, the
threshold probability for RDS at which delivery is delayed,
is set at 15%. The argument for such a lower threshold is
the lower prevalence of RDS at this gestational age. As can
be seen from Table 3, performance of the LBC has limited
impact on the number of women who are delivered despite
fetal lung immaturity, but the number of women who are
delivered in the presence of fetal lung maturity increases
from 9 to 32. Addition of the L/S ratio generates a small
increase in women who are allowed delivery despite fetal
lung immaturity, whereas the number of women who are
delivered correctly increases to 41.
Table 4 shows the situation for a gestational age over
33 weeks. Again, the threshold probability for RDS at
which delivery is delayed, is set at 15%. As can be seen
from this table, performance of the LBC doubles the low
number of women in whom delivery is postponed correctly,
whereas the number of women who are allowed delivery in
the presence of fetal lung maturity does not change. Addi-
tion of the L/S ratio has only limited impact on these num-
bers. From Table 4, it can be seen that any strategy of
assessment of the fetal lung maturity, albeit with invasive
testing or without invasive testing, generates more often a
false positive diagnosis of fetal lung immaturity (i.e. delay
of delivery in presence of fetal lung maturity) than a true
positive diagnosis of fetal lung immaturity (i.e. delay of
delivery in absence of fetal lung maturity). Thus, if delivery
is really warranted due to a high fetal risk, one can question
whether delay of delivery based on assessment of fetal lung
maturity is useful. One should also take into account that
Table 2 ClassiWcation of patients at risk for pre-term delivery as true-positive, false-negative, false-positive, and true-negative, for gestational age
<30 weeks, and based on three prognostic models: (a) model without fetal lung maturity testing (b) model with LBC and (c) model with L/S ratio
The three groups are indexed on 100 patients
Wait correctly Deliver incorrectly Wait incorrectly Deliver correctly
(a) No test 54 7 24 15
(b) LBC 56 5 22 17
(c) L/S ratio 58 3 17 21
Table 3 ClassiWcation of patients at risk for pre-term delivery as true-positive, false-negative, false-positive, and true-negative, for gestational age
30–33 weeks, and based on three prognostic models: (a) model without fetal lung maturity testing (b) model with LBC and (c) model with L/S ratio
The three groups are indexed on 100 patients
Wait correctly Deliver incorrectly Wait incorrectly Deliver correctly
(a) No test 32 1 58 9
(b) LBC 31 2 35 32
(c) L/S ratio 30 3 26 41
Table 4 ClassiWcation of patients at risk for pre-term delivery as true-positive, false-negative, false-positive, and true-negative, for gestational age
>33 weeks, and based on three prognostic models: (a) model without fetal lung maturity testing (b) model with LBC and (c) model with L/S ratio
The three groups are indexed on 100 patients
Wait correctly Deliver incorrectly Wait incorrectly Deliver correctly
(a) No test 2 4 5 89
(b) LBC 4 2 5 89
(c) L/S ratio 5 1 8 86Arch Gynecol Obstet (2010) 281:15–21 21
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Table 4 describes the situation for all pregnancies with a
gestational age >33 weeks. The ratio between false-positive
and true-positive diagnoses of fetal lung immaturity will
increase even more strongly at a gestational age above
38 weeks, when the prevalence of fetal lung immaturity is
below 1% [11]. With such a low prevalence, the ratio
between women in whom delivery is delayed correctly and
women in whom delivery is delayed despite fetal lung
maturity will be lower than 1:20.
Recently, Karcher et al. [12] reported on the accuracy of
the lamellar body count and surfactant-to-albumin ratio in
relation to gestational age in the prediction of RDS. In con-
trast to our study, they only recruited women at a gesta-
tional age >34 weeks. Consequently, the prevalence of
RDS in their study was only 6%. This hampers comparison
with our study. Moreover, the authors did not correct for
veriWcation bias, as we did in the current study.
In summary, we can state that if one wants to assess fetal
lung maturity below 30 weeks the L/S ratio is the procedure
of choice, and that the value of the LBC is limited in these
patients. At a gestational age between 30 and 33 weeks,
assessment of fetal lung maturity with the LBC is useful.
As can be derived from Fig. 2, a probability of RDS below
15% virtually rules out the probability of RDS, whereas at
higher probabilities additional performance of the L/S ratio
is useful. At a gestational age above 33 weeks, the value of
fetal lung maturity assessment is debatable due to the low
prevalence of RDS.
Whether invasive testing for fetal lung maturity is use-
ful, will depend on the eVectiveness of expectant manage-
ment as compared to immediate delivery in fetuses of
which lung maturity tests have indicated mature lungs.
While invasive fetal lungs test predicts the presence of
mature lungs correctly, immediate delivery does not
improve the outcome for mother and infant as compared to
expectant management, then the fetal lung test might be
accurate, but it will not be of value for the patient.
The value of the fetal lung maturity tests will also
depend on the individual clinical situation, for example on
the risk of intrauterine death in case delivery is postponed,
and on the risk of deterioration of the condition of the
mother in case of severe pre-eclampsia. The clinical situa-
tions will diVer in women with fetal growth restriction in
singleton pregnancies, in fetal growth restriction in twin
pregnancies, and in women with severe pre-eclampsia.
Such situations should be addressed in decision analytic
models as well as in new clinical studies on the subject.
Another potential indication for invasive fetal lung test-
ing might be that testing might prevent unnecessary or even
harmful treatment with glucocorticoids. A restrictive use of
these drugs may be achieved by obtaining information on
the status of the fetal lung maturation. This is especially
important in elective (medically indicated) preterm deliver-
ies. In those cases, timing of delivery might depend on
information of the fetal lung maturation. In such cases glu-
cocorticoid administration may be reserved for those cases
in which fetal lung testing has indicated immaturity. This
strategy should be studied in decision analytic models and
possibly also in randomised controlled trials.
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